Stage iv adenocarcinoma of the lung icd 10

NON-SMALL CELL LUNG CANCER

ALTERNATE NAMES

Squamous Cell Lung Carcinoma; Squamous Cell Lung Cancer; Large Cell Lung Carcinoma; Large Cell Lung Cancer; Adenocarcinoma of the Lung; Non-Small Cell Lung Carcinoma; Lung Carcinoma; Bronchioalveolar Carcinoma; Lepidic Adenocarcinoma

DESCRIPTION

Lung Cancer forms in tissues of the lung, usually in the cells lining the air passages. The two main types are Small Cell Lung Cancer and Non-Small Cell Lung Cancer. Diagnosis of the type of cancer is based on microscopic examination. About 87% of lung cancers are Non-Small Cell Lung Cancers. This type spreads more slowly than Small Cell Lung Cancer. The three types of Non-Small Cell Lung Cancer are Squamous Cell Carcinoma, Large Cell Carcinoma, and Adenocarcinoma. Adenocarcinoma has a subdivision of bronchioalveolar carcinoma, which is also known as lepidic adenocarcinoma

DIAGNOSTIC TESTING, PHYSICAL FINDINGS, AND ICD-9-CM/ICD-10-CM CODING

Diagnostic testing: The following may be used to diagnose the extent of disease:

The diagnosis is made from the pathological evaluation of a tumor biopsy. Tumor can be obtained for pathology by needle biopsy or surgical excision.

Physical findings: Early lung cancer often does not cause symptoms. As the cancer progresses, common symptoms may include:

  • Persistent or worsening cough;

  • Frequent lung infections;

  • Unintentional weight loss.

ICD-9: 162.3, 162.9, 231.2, 512.82, 795.81

ICD-10: C34.90

PROGRESSION

Diagnosis in the early stages provides the greatest chance for survival; however, symptoms of Non-Small Cell Lung Cancer usually do not appear until the disease is in an advanced stage. Treatment for Stage IV will not cure the cancer, but can reduce symptoms and extend and improve the quality of life.

The 5-year survival rate for Non-Small Cell Lung Cancer is 15%. Late stage Non-Small Cell Lung Cancer has a 5-year survival rate of less than 5%. Most Non-Small Cell Lung Cancer patients die within a year of diagnosis.

TREATMENT

Treatment of Stage IIIB Non-Small Cell Lung Cancer may include surgery, external radiation therapy, chemotherapy, or a combination of all three. Treatment of Stage IV Non-Small Cell Lung Cancer may include internal radiation therapy, or external radiation as palliative therapy to relieve pain, symptoms, and improve quality of life.

SUGGESTED PROGRAMMATIC ASSESSMENT* Suggested MER for Evaluation:
  • A pathology report and an operative report are the preferred methods for documentation;

  • Clinical note from a surgeon that the cancer is inoperable; and

  • Surgical pathology report that the cancer was not completely removed and that the surgical margins were positive for malignancy.

“Inoperable” refers to a physician's opinion that surgery would not be beneficial based on a review of imaging studies, laboratory results, and physical examination findings. “Unresectable” cancer is established when the operative report indicates that the cancer is not completely removed or the pathology report notes that the surgical specimen has positive margins. Suggested Listings for Evaluation: DETERMINATION

LISTING

REMARKS Meets 13.14 A Non-Small Cell Lung Cancer that is inoperable, unresectable, recurrent, or with metastases to or beyond the hilar nodes meets the criteria in 13.14 A. Equals ​ ​ * Adjudicators may, at their discretion, use the Medical Evidence of Record or the listings suggested to evaluate the claim. However, the decision to allow or deny the claim rests with the adjudicator.

ICD-10 code Z85.118 for Personal history of other malignant neoplasm of bronchus and lung is a medical classification as listed by WHO under the range - Factors influencing health status and contact with health services .

Subscribe to Codify by AAPC and get the code details in a flash.

Official Long Descriptor

Personal history of other malignant neoplasm of bronchus and lung

Conditions classifiable to C34

Z85

Excludes2: personal history of benign neoplasm (Z86.01-)
personal history of carcinoma-in-situ (Z86.00-)

Code first any follow-up examination after treatment of malignant neoplasm (Z08)

Use additional code to identify:
alcohol use and dependence (F10.-)
exposure to environmental tobacco smoke (Z77.22)
history of tobacco dependence (Z87.891)
occupational exposure to environmental tobacco smoke (Z57.31)
tobacco dependence (F17.-)
tobacco use (Z72.0)

Additional/Related Information

Tabs

  • 7th Character Notes
  • Category Notes
  • Chapter Guidelines

Stage iv adenocarcinoma of the lung icd 10

Get crucial instructions for accurate ICD-10-CM Z85.118 coding with all applicable Excludes 1 and Excludes 2 notes from the section level conveniently shown with each code.

This section shows you chapter-specific coding guidelines to increase your understanding and correct usage of the target ICD-10-CM Volume 1 code.

Forum

Have a question around ICD-10-CM Code Z85.118 ? Feel free to start a discussion here

Tabs

[QUOTE=", post: 414634, member: 324930"]Did you look at Z08 with Z90.2 and Z85.118 1. Z08 (Encounter for follow-up examination after completed treatment for malignant neoplasm) 2... [ Read More ]

Did you look at Z08 with Z90.2 and Z85.118 1. Z08 (Encounter for follow-up examination after completed treatment for malignant neoplasm) 2. Z90.2 (Acquired absence of lung [part of]) 3. Z85.118 (Pers... [ Read More ]

I've gotten myself so confused, so I'm hoping you can help me. My case: In 2006, patient has left upper lobe squamous cell carcinoma. Treated with lobectomy and chemo. In 2015, patient returns wi... [ Read More ]

Latest News

Tabs

HISTORY OF PRESENT ILLNESS The patient is a 65yearold female who underwent left upper lobectomy for stage IA nonsmall cell lung cancer. She returns for a routine surveillance visit. She has undergone ... [ Read More ]

What is the ICD

ICD-10 code C34. 31 for Malignant neoplasm of lower lobe, right bronchus or lung is a medical classification as listed by WHO under the range - Malignant neoplasms .

What is the ICD

ICD-10-CM Code for Secondary malignant neoplasm of unspecified site C79. 9.

What is stage IV lung cancer?

Stage IV means the lung cancer has spread to more than 1 area in the other lung, the fluid surrounding the lung or the heart, or distant parts of the body through the bloodstream. Once cancer cells get into the blood, the cancer can spread anywhere in the body.

How do you code adenocarcinoma?

"Adenoma, NOS" is a benign tumor and has the behavior code /0. "Adenocarcinoma, NOS" is the malignant equivalent of "adenoma, NOS" and has the behavior code /3.